1. Home
  2. FCAP vs EMBC Comparison

FCAP vs EMBC Comparison

Compare FCAP & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Capital Inc.

FCAP

First Capital Inc.

N/A

Current Price

$58.30

Market Cap

191.6M

Sector

Finance

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.35

Market Cap

200.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCAP
EMBC
Founded
1891
1924
Country
United States
United States
Employees
N/A
1850
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.6M
200.5M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
FCAP
EMBC
Price
$58.30
$3.35
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
2.5K
3.6M
Earning Date
04-24-2026
05-05-2026
Dividend Yield
2.32%
6.88%
EPS Growth
36.97
20.90
EPS
1.30
0.67
Revenue
$7,170,000.00
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
$47.31
$4.96
Revenue Growth
1.57
N/A
52 Week Low
$33.88
$2.77
52 Week High
$71.00
$15.55

Technical Indicators

Market Signals
Indicator
FCAP
EMBC
Relative Strength Index (RSI) 72.05 24.66
Support Level $49.87 $2.77
Resistance Level $63.70 $9.38
Average True Range (ATR) 1.45 0.23
MACD 0.56 0.17
Stochastic Oscillator 100.00 62.50

Price Performance

Historical Comparison
FCAP
EMBC

About FCAP First Capital Inc.

First Capital Inc is an Indiana chartered commercial bank that provides a variety of banking services to individuals and businesses. It provides retail and business banking, residential mortgage lending, real estate finance, and asset-based lending. The bank's primary source of revenue is real estate mortgage loans.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: